CasNo.105784-83-6,5-IODO-2',3'-DIDEOXYURIDINE,(105784-83-6) Suppliers

1 Gram	Negotiable

Min.Order :1 Gram
Purity: ≥98%
Payment Terms : L/C,D/A,D/P,T/T,

Keywords

2',3'-Dideoxy-5-iodouridine 5-I-ddU; 5-Iodo-2', 3'-dideoxyuridine 2',3'-DIDEOXY-5-IODOURIDINE

Quick Details

Appearance:White to teary white solid powder
Application:For nucleotides
PackAge:Packaging according to actual needs
ProductionCapacity:100|Metric Ton|Year
Storage:2-8°C
Transportation:by sea or by air

Superiority:

Product name:Glycine, N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-, methyl ester, hydrochloride (1:1)
CAS:172405-43-5
Molecular formula:C20H23ClN2O4
Molecular weight:390.86062
EINECS:
MDL No:MFCD09264231
Storage conditions:dry storage at room temperature
Solubility:
Form:
Exterior:White to teary white solid powder
Density:
Acidity coefficient:
Stability:
Melting point:

The Core Team of XH Medic Tech Co.,Ltd. was established on January 20,2022. The company is committed to the research and production of various series of nucleoside/nucleotide blocks (modified nucleoside, monomer, Dimer, Trimer, LNA, etc.), nucleotide phosphate (monophosphate,triphosphate)，GalNAc，R/S thiophosphate oligonucleotide, transfection reagent, etc.The company has a strong R&D capabilityThe director of the company’s research fellows is mainly composed by postdoctoral researcher von the Chinese Academy of Sciences Since its establishment XH has established long-term cooperative relations with companies at home and abroad.XH has been and continue to develop new products, improve process technology to empower customers.

Details:

Product name:Glycine, N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-, methyl ester, hydrochloride (1:1)
CAS:172405-43-5
Molecular formula:C20H23ClN2O4
Molecular weight:390.86062
EINECS:
MDL No:MFCD09264231
Storage conditions:dry storage at room temperature
Solubility:
Form:
Exterior:White to teary white solid powder
Density:
Acidity coefficient:
Stability:
Melting point:

The Core Team of XH Medic Tech Co.,Ltd. was established on January 20,2022. The company is committed to the research and production of various series of nucleoside/nucleotide blocks (modified nucleoside, monomer, Dimer, Trimer, LNA, etc.), nucleotide phosphate (monophosphate,triphosphate)，GalNAc，R/S thiophosphate oligonucleotide, transfection reagent, etc.The company has a strong R&D capabilityThe director of the company’s research fellows is mainly composed by postdoctoral researcher von the Chinese Academy of Sciences Since its establishment XH has established long-term cooperative relations with companies at home and abroad.XH has been and continue to develop new products, improve process technology to empower customers.